Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03734939
Other study ID # 0004
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date November 7, 2018
Est. completion date December 20, 2022

Study information

Verified date May 2021
Source Fundacion GESICA
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cardiovascular risk factors and disease burden has been showed to affect more deeply to poorer populations. People who live in slums are the most vulnerable subgroup in the populations where, paradoxically scarcity of data exists on risk factors and cardiovascular disease burden. Our study aim to describe the prevalence of cardiovascular risk factors and cardiovascular disease burden in a representative sample of an urban slum of Buenos Aires city, using validated questions from the National Risk Factors Survey (edition 2013). Also, the investigators will measure blood pressure and cardiac rate to all study participants.


Description:

Cardiovascular risk factors and disease burden has been showed to affect more deeply to poorer populations. People who live in slums are the most vulnerable subgroup in the populations where, paradoxically scarcity of data exists on risk factors and cardiovascular disease burden. Hypothesis: the prevalence of modifiable cardiovascular risk factors in an urban slum from Buenos Aires city is higher than the rest of the country and, consequently requires a distinctive management approach. Objectives: 1. To measure the prevalence of cardiovascular risk factors in a representative sample of the villa 31 (an urban slum from Buenos Aires city). 2. To measure the self-perceived health in a representative sample of the villa 31 (urban slum from Buenos Aires city). Design: observational study. Survey. Procedures: the survey will be conducted by neighbors from the slum that received specific training as community health workers and were trained on the use of the survey questionnaire and for blood pressure measuring. Sampling: representative samples of slum population will be obtained using probabilistic, multi-staged sampling methods. Blood pressure measures: blood pressure will be measured using automatic blood pressure monitoring device with appropriate cuff sizes. Statistical analyses: categorical variables will be expressed as numbers and percentages, and continuous variable as means and standard deviations or medians and interquartile ranges. Between groups comparisons will be conducted using chi2 test for categorical variables and T test or Mann-Whitney U's test for continuous variables. To compare the prevalence of risk factors with the rest of the country, the database will be jointed with the national risk factor survey (publicly available). All analyses will be weighted to account for the sampling method.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 2265
Est. completion date December 20, 2022
Est. primary completion date December 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: >= 18 years. Sign the informed consent. - Exclusion Criteria: Unable to answer the survey. Unwilling to participate. -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
None intervention is planned.
None intervention is planned, just a survey.

Locations

Country Name City State
Argentina Fundación GESICA Ciudad Autónoma de Buenos Aire Buenos Aires

Sponsors (3)

Lead Sponsor Collaborator
Fundacion GESICA Corriente Salvador Maza, Escuela de Psicología Social Pichon Riviere

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hypertension Blood pressure >=140/90 mmHg or being taking antihypertensive medication. Through study completion, an average of 3 months
Primary Smoking Percentage of participants that self-report current smoking Through study completion, an average of 3 months
Primary Hypercholesterolemia Self-reported plasma high cholesterol levels. Through study completion, an average of 3 months
Primary Diabetes Percentage of participants that self-report as had been diagnosed as diabetic or receiving medical therapy for diabetes. Through study completion, an average of 3 months
Primary Self-perceived health Percentage of participants that report their health status as self-perceived in a 5-points Likert' scale from "Excellent" to "Bad" Through study completion, an average of 3 months
Secondary Previous myocardial infarction Self-reported history of myocardial infarction. through study completion, an average of 3 months
Secondary Previous stroke Self-reported history of stroke. through study completion, an average of 3 months
Secondary Physical activity Percentage of participants with self-reported physical activity levels in a Likert' scale (from "Less than 10 min/week" to "Equal or more than 150 min/week"). Through study completion, an average of 3 months
Secondary Healthy diet Self-reported consumption of vegetables and fruits. through study completion, an average of 3 months
Secondary Body mass index Body weight divided by the height squared in meters (both body weight and height as self-reported. through study completion, an average of 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)